Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	CD4 receptor binding	PLSCR4 PLSCR2 PLSCR1	8.22e-06	11	75	3	GO:0042609
GeneOntologyMolecularFunction	lead ion binding	PLSCR2 PLSCR1	4.17e-05	3	75	2	GO:0032791
GeneOntologyMolecularFunction	phospholipid scramblase activity	PLSCR4 PLSCR2 PLSCR1	8.54e-05	23	75	3	GO:0017128
GeneOntologyMolecularFunction	transporter activity	PLSCR4 SLC4A8 SLC10A2 SLC12A4 SLC39A3 KCNJ2 KCNJ3 SCN10A CACNA1H PLSCR2 FXYD3 SLC1A4 PLSCR1 SLC2A3	2.78e-04	1289	75	14	GO:0005215
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	SLC4A8 SLC10A2 SLC12A4 SLC39A3 KCNJ2 KCNJ3 SCN10A CACNA1H	3.51e-04	465	75	8	GO:0046873
GeneOntologyMolecularFunction	mercury ion binding	PLSCR2 PLSCR1	3.84e-04	8	75	2	GO:0045340
GeneOntologyMolecularFunction	epidermal growth factor receptor binding	MS4A1 PLSCR2 PLSCR1	4.90e-04	41	75	3	GO:0005154
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	SLC4A8 SLC10A2 SLC12A4 SLC39A3 KCNJ2 KCNJ3 SCN10A CACNA1H FXYD3 SLC1A4	5.22e-04	758	75	10	GO:0015318
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	SLC4A8 SLC10A2 SLC12A4 SLC39A3 KCNJ2 KCNJ3 SCN10A CACNA1H FXYD3 SLC1A4	7.40e-04	793	75	10	GO:0015075
GeneOntologyMolecularFunction	intramembrane lipid transporter activity	PLSCR4 PLSCR2 PLSCR1	9.31e-04	51	75	3	GO:0140303
GeneOntologyMolecularFunction	chloride transmembrane transporter activity	SLC4A8 SLC12A4 FXYD3 SLC1A4	1.26e-03	125	75	4	GO:0015108
GeneOntologyMolecularFunction	voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization	KCNJ2 KCNJ3	1.42e-03	15	75	2	GO:0086008
GeneOntologyMolecularFunction	nuclear receptor activity	THRA ESR1 VDR	1.49e-03	60	75	3	GO:0004879
GeneOntologyMolecularFunction	ligand-activated transcription factor activity	THRA ESR1 VDR	1.57e-03	61	75	3	GO:0098531
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential	KCNJ3 SCN10A	1.83e-03	17	75	2	GO:0099508
GeneOntologyMolecularFunction	magnesium ion binding	ADCY10 MSH6 PKLR PLSCR2 PLSCR1	2.37e-03	247	75	5	GO:0000287
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	SLC4A8 SLC10A2 SLC12A4 SLC39A3 KCNJ2 KCNJ3 SCN10A CACNA1H	2.40e-03	627	75	8	GO:0022890
GeneOntologyMolecularFunction	symporter activity	SLC4A8 SLC10A2 SLC12A4 SLC1A4	2.46e-03	150	75	4	GO:0015293
GeneOntologyMolecularFunction	monoatomic anion transmembrane transporter activity	SLC4A8 SLC12A4 FXYD3 SLC1A4	2.52e-03	151	75	4	GO:0008509
GeneOntologyMolecularFunction	phospholipid transporter activity	PLSCR4 PLSCR2 PLSCR1	2.72e-03	74	75	3	GO:0005548
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	SLC4A8 SLC10A2 SLC12A4 SLC39A3 KCNJ2 KCNJ3 SCN10A CACNA1H	3.41e-03	664	75	8	GO:0008324
GeneOntologyMolecularFunction	channel activity	SLC12A4 KCNJ2 KCNJ3 SCN10A CACNA1H FXYD3 SLC1A4	3.54e-03	525	75	7	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	SLC12A4 KCNJ2 KCNJ3 SCN10A CACNA1H FXYD3 SLC1A4	3.58e-03	526	75	7	GO:0022803
GeneOntologyMolecularFunction	inorganic anion transmembrane transporter activity	SLC4A8 SLC12A4 FXYD3 SLC1A4	3.93e-03	171	75	4	GO:0015103
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	SLC4A8 SLC10A2 SCN10A CACNA1H	3.93e-03	171	75	4	GO:0015081
GeneOntologyMolecularFunction	virus receptor activity	PLSCR2 PLSCR1 CLDN1	4.03e-03	85	75	3	GO:0001618
GeneOntologyMolecularFunction	exogenous protein binding	PLSCR2 PLSCR1 CLDN1	4.17e-03	86	75	3	GO:0140272
GeneOntologyMolecularFunction	voltage-gated sodium channel activity	SCN10A CACNA1H	4.27e-03	26	75	2	GO:0005248
GeneOntologyMolecularFunction	transmembrane transporter activity	SLC4A8 SLC10A2 SLC12A4 SLC39A3 KCNJ2 KCNJ3 SCN10A CACNA1H FXYD3 SLC1A4 SLC2A3	4.42e-03	1180	75	11	GO:0022857
GeneOntologyMolecularFunction	transition metal ion binding	ADCY10 TES SLC4A8 THRA ADAMTS9 DTNA CYP3A43 ESR1 PLSCR2 PLSCR1 VDR	4.67e-03	1189	75	11	GO:0046914
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity	KCNJ2 KCNJ3 SCN10A CACNA1H	4.91e-03	182	75	4	GO:0005244
GeneOntologyMolecularFunction	inward rectifier potassium channel activity	KCNJ2 KCNJ3	4.94e-03	28	75	2	GO:0005242
GeneOntologyMolecularFunction	voltage-gated channel activity	KCNJ2 KCNJ3 SCN10A CACNA1H	5.10e-03	184	75	4	GO:0022832
GeneOntologyBiologicalProcess	actin filament-based movement	ADCY10 MYO6 KCNJ2 KCNJ3 SCN10A CACNA1H	2.15e-05	153	76	6	GO:0030048
GeneOntologyBiologicalProcess	import across plasma membrane	SLC12A4 MS4A1 KCNJ2 KCNJ3 CACNA1H SLC1A4 SLC2A3	2.23e-05	230	76	7	GO:0098739
GeneOntologyBiologicalProcess	cardiac muscle cell contraction	ADCY10 KCNJ2 KCNJ3 SCN10A CACNA1H	2.40e-05	93	76	5	GO:0086003
GeneOntologyBiologicalProcess	metal ion transport	SLC4A8 SLC10A2 SLC12A4 SLC39A3 MS4A1 KCNJ2 KCNJ3 SCN10A CD63 CACNA1H FXYD3 CXCL11 VDR	6.74e-05	1000	76	13	GO:0030001
GeneOntologyBiologicalProcess	inorganic ion transmembrane transport	SLC4A8 SLC12A4 SLC39A3 MS4A1 KCNJ2 KCNJ3 SCN10A CD63 CACNA1H FXYD3 CXCL11 SLC1A4 VDR	7.99e-05	1017	76	13	GO:0098660
GeneOntologyBiologicalProcess	response to lead ion	PTH PLSCR1 CLDN1	1.04e-04	25	76	3	GO:0010288
GeneOntologyBiologicalProcess	actin-mediated cell contraction	ADCY10 KCNJ2 KCNJ3 SCN10A CACNA1H	1.06e-04	127	76	5	GO:0070252
GeneOntologyBiologicalProcess	plasma membrane phospholipid scrambling	PLSCR4 PLSCR2 PLSCR1	1.18e-04	26	76	3	GO:0017121
GeneOntologyBiologicalProcess	inorganic anion transmembrane transport	SLC4A8 SLC12A4 FXYD3 SLC1A4 VDR	1.37e-04	134	76	5	GO:0098661
GeneOntologyBiologicalProcess	striated muscle contraction	ADCY10 DTNA KCNJ2 KCNJ3 SCN10A CACNA1H	1.50e-04	217	76	6	GO:0006941
GeneOntologyBiologicalProcess	inorganic ion import across plasma membrane	SLC12A4 MS4A1 KCNJ2 KCNJ3 CACNA1H	1.80e-04	142	76	5	GO:0099587
GeneOntologyBiologicalProcess	inorganic cation import across plasma membrane	SLC12A4 MS4A1 KCNJ2 KCNJ3 CACNA1H	1.80e-04	142	76	5	GO:0098659
GeneOntologyBiologicalProcess	mammary gland branching involved in pregnancy	ESR1 VDR	2.78e-04	7	76	2	GO:0060745
GeneOntologyBiologicalProcess	monoatomic cation transport	SLC4A8 SLC10A2 SLC12A4 SLC39A3 MS4A1 KCNJ2 KCNJ3 SCN10A CD63 CACNA1H FXYD3 CXCL11 VDR	2.87e-04	1157	76	13	GO:0006812
GeneOntologyBiologicalProcess	regulation of transmembrane transport	MS4A1 KCNJ2 KCNJ3 ESR1 SCN10A CD63 FXYD3 CXCL11 PTH	3.08e-04	589	76	9	GO:0034762
GeneOntologyBiologicalProcess	membrane depolarization during action potential	KCNJ2 SCN10A CACNA1H	3.14e-04	36	76	3	GO:0086010
GeneOntologyBiologicalProcess	regulation of heart contraction	ADCY10 THRA KCNJ2 KCNJ3 SCN10A CACNA1H	3.15e-04	249	76	6	GO:0008016
GeneOntologyBiologicalProcess	regulation of cardiac muscle contraction	ADCY10 KCNJ2 SCN10A CACNA1H	3.28e-04	89	76	4	GO:0055117
GeneOntologyBiologicalProcess	circulatory system process	TBC1D8 ADCY10 SLC4A8 THRA KCNJ2 KCNJ3 SCN10A CACNA1H SLC1A4 SLC2A3	3.47e-04	733	76	10	GO:0003013
GeneOntologyBiologicalProcess	cardiac muscle contraction	ADCY10 KCNJ2 KCNJ3 SCN10A CACNA1H	3.81e-04	167	76	5	GO:0060048
GeneOntologyBiologicalProcess	monoatomic ion transport	SLC4A8 SLC10A2 SLC12A4 SLC39A3 MS4A1 KCNJ2 KCNJ3 SCN10A CD63 CACNA1H FXYD3 CXCL11 SLC1A4 VDR	4.41e-04	1374	76	14	GO:0006811
GeneOntologyBiologicalProcess	regulation of cardiac muscle cell contraction	ADCY10 KCNJ2 CACNA1H	5.34e-04	43	76	3	GO:0086004
GeneOntologyBiologicalProcess	inorganic anion transport	SLC4A8 SLC12A4 FXYD3 SLC1A4 VDR	5.36e-04	180	76	5	GO:0015698
GeneOntologyBiologicalProcess	inorganic cation transmembrane transport	SLC4A8 SLC12A4 SLC39A3 MS4A1 KCNJ2 KCNJ3 SCN10A CD63 CACNA1H FXYD3 CXCL11	5.37e-04	922	76	11	GO:0098662
GeneOntologyCellularComponent	sarcolemma	DTNA KCNJ2 KCNJ3 ESR1 CACNA1H VDR	7.23e-05	190	77	6	GO:0042383
GeneOntologyCellularComponent	T-tubule	KCNJ2 KCNJ3 ESR1 VDR	2.07e-04	79	77	4	GO:0030315
Domain	Scramblase	PLSCR4 PLSCR2 PLSCR1	5.94e-07	5	74	3	PF03803
Domain	Scramblase	PLSCR4 PLSCR2 PLSCR1	5.94e-07	5	74	3	IPR005552
Domain	zf-C4	THRA ESR1 VDR	8.02e-04	46	74	3	PF00105
Domain	Znf_hrmn_rcpt	THRA ESR1 VDR	8.02e-04	46	74	3	IPR001628
Domain	Nuclear_hrmn_rcpt	THRA ESR1 VDR	8.02e-04	46	74	3	IPR001723
Domain	NUCLEAR_REC_DBD_2	THRA ESR1 VDR	8.02e-04	46	74	3	PS51030
Domain	NUCLEAR_REC_DBD_1	THRA ESR1 VDR	8.02e-04	46	74	3	PS00031
Domain	ZnF_C4	THRA ESR1 VDR	8.02e-04	46	74	3	SM00399
Domain	-	THRA ESR1 VDR	8.54e-04	47	74	3	1.10.565.10
Domain	HOLI	THRA ESR1 VDR	9.09e-04	48	74	3	SM00430
Domain	Nucl_hrmn_rcpt_lig-bd	THRA ESR1 VDR	9.09e-04	48	74	3	IPR000536
Domain	Hormone_recep	THRA ESR1 VDR	9.09e-04	48	74	3	PF00104
Domain	-	THRA ESR1 VDR	1.50e-03	57	74	3	3.30.50.10
Domain	Znf_NHR/GATA	THRA ESR1 VDR	1.58e-03	58	74	3	IPR013088
Domain	GRAM	TBC1D8 MTMR1	1.79e-03	16	74	2	SM00568
Domain	K_chnl_inward-rec_Kir_cyto	KCNJ2 KCNJ3	1.79e-03	16	74	2	IPR013518
Domain	IRK	KCNJ2 KCNJ3	1.79e-03	16	74	2	PF01007
Domain	-	KCNJ2 KCNJ3	1.79e-03	16	74	2	2.60.40.1400
Domain	K_chnl_inward-rec_Kir	KCNJ2 KCNJ3	1.79e-03	16	74	2	IPR016449
Domain	ARM-type_fold	ARFGEF3 GPRASP1 ZER1 CTIF HUWE1 TNPO3	2.25e-03	339	74	6	IPR016024
Domain	Tetraspanin_CS	CD63 TSPAN3	3.10e-03	21	74	2	IPR018503
Domain	GRAM	TBC1D8 MTMR1	3.40e-03	22	74	2	PF02893
Domain	GRAM	TBC1D8 MTMR1	3.40e-03	22	74	2	IPR004182
Domain	-	TBC1D8 EFCAB5 DTNA SPATA21 PLS1	3.77e-03	261	74	5	1.10.238.10
Domain	TM4_1	CD63 TSPAN3	4.73e-03	26	74	2	PS00421
Domain	EF-hand-dom_pair	TBC1D8 EFCAB5 DTNA SPATA21 PLS1	5.62e-03	287	74	5	IPR011992
Domain	Tetraspanin	CD63 TSPAN3	7.11e-03	32	74	2	IPR000301
Domain	Tetraspanin_EC2	CD63 TSPAN3	7.11e-03	32	74	2	IPR008952
Domain	Tetraspannin	CD63 TSPAN3	7.55e-03	33	74	2	PF00335
Domain	Tetraspanin/Peripherin	CD63 TSPAN3	7.55e-03	33	74	2	IPR018499
Pathway	KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY	ESR1 CCND1	1.13e-04	5	48	2	M48983
Pathway	REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS	THRA ESR1 VDR	1.14e-04	28	48	3	MM15042
Pathway	REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS	THRA ESR1 VDR	1.41e-04	30	48	3	M27323
Pubmed	Identification of three new members of the phospholipid scramblase gene family.	PLSCR4 PLSCR2 PLSCR1	4.00e-08	4	76	3	10930526
Pubmed	Calcium binding studies of peptides of human phospholipid scramblases 1 to 4 suggest that scramblases are new class of calcium binding proteins in the cell.	PLSCR4 PLSCR2 PLSCR1	4.00e-08	4	76	3	19540310
Pubmed	Distinct association of gene polymorphisms of estrogen receptor and vitamin D receptor with lumbar spondylosis in post-menopausal women.	ESR1 PTH VDR	4.00e-08	4	76	3	16362385
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	PLSCR4 SLC4A8 SLC12A4 DTNA ANKRD26 MTMR1 MAPK13 SLC1A4 VPS13B SLC2A3 CLDN1	4.48e-08	569	76	11	30639242
Pubmed	Association of gene polymorphisms and bone density in Japanese girls.	ESR1 PTH VDR	1.00e-07	5	76	3	11984699
Pubmed	Association of bone metabolism regulatory factor gene polymorphisms with susceptibility to ossification of the posterior longitudinal ligament of the spine and its severity.	ESR1 PTH VDR	1.00e-07	5	76	3	12195069
Pubmed	Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes.	SLC10A2 CCND1 VDR	1.00e-07	5	76	3	17960397
Pubmed	Contribution of genotype and ethnicity to bone mineral density variation in Caucasians and Chinese: a test for five candidate genes for bone mass.	ESR1 PTH VDR	1.00e-07	5	76	3	16117875
Pubmed	Differentiation of Caucasians and Chinese at bone mass candidate genes: implication for ethnic difference of bone mass.	ESR1 PTH VDR	1.00e-07	5	76	3	12914574
Pubmed	Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response.	PLSCR4 PLSCR2 PLSCR1	2.00e-07	6	76	3	17590392
Pubmed	T:G mismatch-specific thymine-DNA glycosylase potentiates transcription of estrogen-regulated genes through direct interaction with estrogen receptor alpha.	THRA ESR1 VDR	8.34e-07	9	76	3	12874288
Pubmed	The TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion.	THRA ESR1 VDR	1.19e-06	10	76	3	9653119
Pubmed	A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.	ESR1 PTH VDR	1.63e-06	11	76	3	18285546
Pubmed	A new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB-binding protein.	THRA ESR1 VDR	2.17e-06	12	76	3	10866662
Pubmed	TIF1delta, a novel HP1-interacting member of the transcriptional intermediary factor 1 (TIF1) family expressed by elongating spermatids.	THRA ESR1 VDR	2.82e-06	13	76	3	15322135
Pubmed	Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1.	THRA ESR1 VDR	2.82e-06	13	76	3	9115274
Pubmed	Relation of the estrogen receptor and vitamin D receptor polymorphisms with bone mineral density in postmenopausal Mexican-mestizo women.	ESR1 VDR	4.71e-06	2	76	2	24389498
Pubmed	Vitamin D and oestrogen receptor polymorphisms in developmental dysplasia of the hip and primary protrusio acetabuli--a preliminary study.	ESR1 VDR	4.71e-06	2	76	2	17598904
Pubmed	Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists.	ESR1 CCND1	4.71e-06	2	76	2	18632615
Pubmed	Effects of vitamin D and estrogen receptor gene polymorphisms on the changes in lumbar bone mineral density with multiple pregnancies in Japanese women.	ESR1 VDR	4.71e-06	2	76	2	14688157
Pubmed	[Association of bone mineral density with gene polymorphisms and environmental factors in Chinese postmenopausal women].	ESR1 VDR	4.71e-06	2	76	2	16758971
Pubmed	[Study on the relationship between some genetic factors and peak bone mineral density in Beijing young women].	ESR1 VDR	4.71e-06	2	76	2	12895309
Pubmed	The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer.	ESR1 VDR	4.71e-06	2	76	2	21703046
Pubmed	Differential Regulation of POC5 by ERα in Human Normal and Scoliotic Cells.	ESR1 POC5	4.71e-06	2	76	2	37239471
Pubmed	Evaluation of the effects of vitamin D receptor and estrogen receptor 1 gene polymorphisms on bone mineral density in postmenopausal women.	ESR1 VDR	4.71e-06	2	76	2	20697762
Pubmed	CDK-independent activation of estrogen receptor by cyclin D1.	ESR1 CCND1	4.71e-06	2	76	2	9039267
Pubmed	Interaction effects between estrogen receptor alpha and vitamin D receptor genes on age at menarche in Chinese women.	ESR1 VDR	4.71e-06	2	76	2	15960894
Pubmed	Vitamin D and estrogen receptor-alpha genotype and indices of bone mass and bone turnover in Danish girls.	ESR1 VDR	4.71e-06	2	76	2	16816928
Pubmed	Loss of cyclin D1 in concert with deregulated estrogen receptor alpha expression induces DNA damage response activation and interrupts mammary gland morphogenesis.	ESR1 CCND1	4.71e-06	2	76	2	18071314
Pubmed	Association between VDR and ESR1 gene polymorphisms with bone and obesity phenotypes in Chinese male nuclear families.	ESR1 VDR	4.71e-06	2	76	2	19960008
Pubmed	Stimulation of phosphatidylserine biosynthesis and facilitation of UV-induced apoptosis in Chinese hamster ovary cells overexpressing phospholipid scramblase 1.	PLSCR2 PLSCR1	4.71e-06	2	76	2	12509439
Pubmed	Evaluation of ERα and VDR gene polymorphisms in relation to bone mineral density in Turkish postmenopausal women.	ESR1 VDR	4.71e-06	2	76	2	22311020
Pubmed	Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women.	ESR1 VDR	4.71e-06	2	76	2	16791482
Pubmed	Inhibition of Cav 3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammation.	SCN10A CACNA1H	4.71e-06	2	76	2	30714145
Pubmed	Genetic Polymorphisms in the ESR1 and VDR Genes Do Not Correlate With Osteoporosis in Patients With Familial Dysautonomia.	ESR1 VDR	4.71e-06	2	76	2	28161223
Pubmed	Biphasic ER-α36-mediated estrogen signaling regulates growth of gastric cancer cells.	ESR1 CCND1	4.71e-06	2	76	2	25231129
Pubmed	Association of vitamin D receptor and estrogen receptor gene polymorphisms with bone mass in postmenopausal Korean women.	ESR1 VDR	4.71e-06	2	76	2	11355046
Pubmed	Association of vitamin D receptor and estrogen receptor-alpha gene polymorphism with peak bone mass and bone size in Chinese women.	ESR1 VDR	4.71e-06	2	76	2	15066214
Pubmed	Identity of a conserved motif in phospholipid scramblase that is required for Ca2+-accelerated transbilayer movement of membrane phospholipids.	PLSCR2 PLSCR1	4.71e-06	2	76	2	9485382
Pubmed	Possible association of combined vitamin D receptor and estrogen receptor genotypes and low bone mineral density in Jordanian postmenopausal women.	ESR1 VDR	4.71e-06	2	76	2	19814616
Pubmed	Genotypes and clinical aspects associated with bone mineral density in Argentine postmenopausal women.	ESR1 VDR	4.71e-06	2	76	2	18600402
Pubmed	Genetic Loss of IK1 Causes Adrenergic-Induced Phase 3 Early Afterdepolariz ations and Polymorphic and Bidirectional Ventricular Tachycardia.	KCNJ2 KCNJ3	4.71e-06	2	76	2	32931337
Pubmed	Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy.	ESR1 CCND1	4.71e-06	2	76	2	31112577
Pubmed	The association of lumbar disc disease with vitamin-D receptor gene polymorphism.	ESR1 VDR	4.71e-06	2	76	2	12429765
Pubmed	Dystrobrevin alpha gene is a direct target of the vitamin D receptor in muscle.	DTNA VDR	4.71e-06	2	76	2	31940280
Pubmed	Association of estrogen receptor-alpha and vitamin D receptor genotypes with therapeutic response to calcium in postmenopausal Chinese women.	ESR1 VDR	4.71e-06	2	76	2	15569417
Pubmed	Does vitamin D supplementation of healthy Danish Caucasian girls affect bone turnover and bone mineralization?	ESR1 VDR	4.71e-06	2	76	2	19735754
Pubmed	N-terminal proline-rich domain is required for scrambling activity of human phospholipid scramblases.	PLSCR2 PLSCR1	4.71e-06	2	76	2	24648509
Pubmed	Pyruvate kinase L/R links metabolism dysfunction to neuroendocrine differentiation of prostate cancer by ZBTB10 deficiency.	PKLR ZBTB10	4.71e-06	2	76	2	35306527
Pubmed	A region of the muscarinic-gated atrial K+ channel critical for activation by G protein beta gamma subunits.	KCNJ2 KCNJ3	4.71e-06	2	76	2	7917304
Pubmed	Vitamin D and estrogen receptor gene polymorphisms and the risk of colorectal cancer in Bulgaria.	ESR1 VDR	4.71e-06	2	76	2	16788818
Pubmed	Genome-wide study of ER-regulated lncRNAs shows AP000439.3 may function as a key regulator of cell cycle in breast cancer.	ESR1 CCND1	4.71e-06	2	76	2	29048636
Pubmed	Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia.	PTH VDR	4.71e-06	2	76	2	9275211
Pubmed	Cyclin D1 provides a link between development and oncogenesis in the retina and breast.	ESR1 CCND1	4.71e-06	2	76	2	7664341
Pubmed	Vitamin D Receptor in Breast Cancer Tissues and Its Relation to Estrogen Receptor Alpha (ER-α) Gene Expression and Serum 25-hydroxyvitamin D Levels in Egyptian Breast Cancer Patients: A Case-control Study.	ESR1 VDR	4.71e-06	2	76	2	30833174
Pubmed	Genotypes of vitamin D and estrogen receptors in pre and perimenopausal women from Córdoba, Argentina.	ESR1 VDR	4.71e-06	2	76	2	17408018
Pubmed	Regulation of the functional interaction between cyclin D1 and the estrogen receptor.	ESR1 CCND1	4.71e-06	2	76	2	11073968
Pubmed	Association of polymorphisms in estrogen and thyroid hormone receptors with thyroid cancer risk.	THRA ESR1	4.71e-06	2	76	2	19519176
Pubmed	Estrogen receptor alpha and vitamin D receptor gene polymorphisms and bone mineral density: association study of healthy pre- and postmenopausal Chinese women.	ESR1 VDR	4.71e-06	2	76	2	12927786
Pubmed	Association of oestrogen receptor gene polymorphism with the long-term results of rotational acetabular osteotomy.	ESR1 VDR	4.71e-06	2	76	2	19219433
Pubmed	Cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on estrogen receptor alpha-mediated transcription.	ESR1 CCND1	4.71e-06	2	76	2	19956831
Pubmed	Effect of vitamin D receptor and estrogen receptor gene polymorphism on the relationship between dietary calcium and bone mineral density in Japanese women.	ESR1 VDR	4.71e-06	2	76	2	14999525
Pubmed	Influence of vitamin D and estrogen receptor gene polymorphisms on calcium absorption: BsmI predicts a greater decrease during energy restriction.	ESR1 VDR	4.71e-06	2	76	2	26165414
Pubmed	Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphisms in Asian Indians.	PTH VDR	4.71e-06	2	76	2	16762954
Pubmed	Interaction effects between estrogen receptor alpha gene, vitamin D receptor gene, age, and sex on bone mineral density in Chinese.	ESR1 VDR	4.71e-06	2	76	2	14505233
Pubmed	Association of vitamin D receptor BsmI (rs1544410) gene polymorphism with the intact parathyroid hormone (iPTH) level among patients with end-stage renal disease.	PTH VDR	4.71e-06	2	76	2	25007156
Pubmed	Polymorphisms in vitamin D receptor and parathyroid hormone genes in the development and progression of obstructive sleep apnea in Asian Indians.	PTH VDR	4.71e-06	2	76	2	33895557
Pubmed	Parathyroid hormone gene variant and calcific aortic stenosis.	PTH VDR	4.71e-06	2	76	2	19557980
Pubmed	E3 Ubiquitin Ligase ASB14 Inhibits Cardiomyocyte Proliferation by Regulating MAPRE2 Ubiquitination.	ASB14 MAPRE2	4.71e-06	2	76	2	38319584
Pubmed	The bone mass density in postmenopausal women using hormonal replacement therapy in relation to polymorphism in vitamin D receptor and estrogen receptor genes.	ESR1 VDR	4.71e-06	2	76	2	19903038
Pubmed	Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis.	ESR1 VDR	4.71e-06	2	76	2	12169981
Pubmed	Interaction between vitamin D receptor genotype and estrogen receptor alpha genotype influences vertebral fracture risk.	ESR1 VDR	4.71e-06	2	76	2	12915669
Pubmed	Genomic and metabolomic patterns segregate with responses to calcium and vitamin D supplementation.	ESR1 VDR	4.71e-06	2	76	2	20727239
Pubmed	Phospholipid scramblase expression in the pregnant mouse uterus in LPS-induced preterm delivery.	PLSCR4 PLSCR1	4.71e-06	2	76	2	22598484
Pubmed	The Low-Threshold Calcium Channel Cav3.2 Determines Low-Threshold Mechanoreceptor Function.	SCN10A CACNA1H	4.71e-06	2	76	2	25600872
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	MXRA5 MYO6 RBL2 PSMB3 SCN10A PKLR CD63 HUWE1 PLS1 PLSCR1 TSPAN3	1.27e-05	1016	76	11	19056867
Pubmed	Oestrogen receptor alpha genotype, and interactions between vitamin D receptor and transforming growth factor-beta1 genotypes are associated with quantitative calcaneal ultrasound in postmenopausal women.	ESR1 VDR	1.41e-05	3	76	2	14725686
Pubmed	Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase.	PTH VDR	1.41e-05	3	76	2	15601867
Pubmed	Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Ialpha1 genes and their relationship with height in children with bone cancer.	ESR1 VDR	1.41e-05	3	76	2	14528100
Pubmed	Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin, and parathyroid hormone with bone mineral density.	PTH VDR	1.41e-05	3	76	2	11918225
Pubmed	MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.	ESR1 ZBTB10	1.41e-05	3	76	2	20382698
Pubmed	The actin-binding protein, actinin alpha 4 (ACTN4), is a nuclear receptor coactivator that promotes proliferation of MCF-7 breast cancer cells.	ESR1 VDR	1.41e-05	3	76	2	21078666
Pubmed	Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review.	ESR1 VDR	1.41e-05	3	76	2	15692074
Pubmed	Genetic control of bone density and turnover: role of the collagen 1alpha1, estrogen receptor, and vitamin D receptor genes.	ESR1 VDR	1.41e-05	3	76	2	11316004
Pubmed	Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.	ESR1 CCND1	1.41e-05	3	76	2	16061635
Pubmed	Cloning and characterization of a novel WD-40 repeat protein that dramatically accelerates osteoblastic differentiation.	ARFGEF3 PTH	1.41e-05	3	76	2	11551928
Pubmed	Genetic predispositions and the short- and long-term effects of hormonal therapy on bone mineral density in girls with functional hypothalamic amenorrhoea.	ESR1 VDR	1.41e-05	3	76	2	23338998
Pubmed	Claudin-1 expression decreases with increasing pathological grade in actinic keratosis and may be a marker of high-risk actinic keratosis.	CLDN1 VDR	1.41e-05	3	76	2	30315595
Pubmed	Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.	ESR1 CXCL11	1.41e-05	3	76	2	30051594
Pubmed	Genetic and environmental determinants of peak bone mass in young men and women.	ESR1 VDR	1.41e-05	3	76	2	12096841
Pubmed	Use of genetically modified mice to examine the skeletal anabolic activity of vitamin D.	PTH VDR	1.41e-05	3	76	2	17254773
Pubmed	Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter.	ESR1 CCND1	1.41e-05	3	76	2	15282324
Pubmed	In vitro and in vivo roles of glucocorticoid and vitamin D receptors in the control of neonatal cardiomyocyte proliferative potential.	THRA VDR	1.41e-05	3	76	2	32289320
Pubmed	Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression.	ESR1 CCND1	1.41e-05	3	76	2	11986316
Pubmed	Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.	ESR1 VDR	1.41e-05	3	76	2	16604479
Pubmed	Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties.	THRA VDR	1.41e-05	3	76	2	10409738
Pubmed	[High expression of cyclin D1 is correlated with the expression of estrogen receptor and good prognosis in breast cancer].	ESR1 CCND1	1.41e-05	3	76	2	26728382
Pubmed	[The relativity between chronic periodontitis and the genetic polymorphisms of vitamin D receptor and estrogen receptor].	ESR1 VDR	1.41e-05	3	76	2	18846948
Pubmed	Influence of genetic polymorphisms on bone disease of preterm infants.	ESR1 VDR	1.41e-05	3	76	2	16988190
Pubmed	Genetic effects of estrogen receptor alpha and collagen IA1 genes on the relationships of parathyroid hormone and 25 hydroxyvitamin D with bone mineral density in Caucasian women.	ESR1 PTH	1.41e-05	3	76	2	14506618
Interaction	LGALS9C interactions	SLC12A4 CD63 PLSCR1 TSPAN3	7.62e-06	35	73	4	int:LGALS9C
Cytoband	Ensembl 112 genes in cytogenetic band chr3q24	PLSCR4 PLSCR2 PLSCR1	6.97e-05	47	77	3	chr3q24
Cytoband	3q24	PLSCR4 PLSCR2	1.25e-03	31	77	2	3q24
Cytoband	22q12.1	TPST2 TFIP11	1.33e-03	32	77	2	22q12.1
GeneFamily	Phospholipid scramblases	PLSCR4 PLSCR2 PLSCR1	3.29e-07	5	59	3	954
GeneFamily	Nuclear hormone receptors	THRA ESR1 VDR	5.47e-04	49	59	3	71
GeneFamily	Potassium voltage-gated channel subfamily J	KCNJ2 KCNJ3	1.22e-03	16	59	2	276
GeneFamily	Solute carriers	SLC4A8 SLC10A2 SLC12A4 SLC39A3 SLC1A4 SLC2A3	1.78e-03	395	59	6	752
GeneFamily	CD molecules\|Tetraspanins	CD63 TSPAN3	5.18e-03	33	59	2	768
Coexpression	GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP	SLC4A8 ZBTB10 CXCL11 PLSCR1 DENND3 TSPAN3 VDR	1.68e-06	199	75	7	M9786
Coexpression	STEIN_ESRRA_TARGETS_DN	MSH6 MYO6 PLS1 CLDN1 VDR	1.29e-05	105	75	5	M18160
Coexpression	HOSHIDA_LIVER_CANCER_SURVIVAL_DN	MSH6 KCNJ3 PSMB3 PKLR ZER1	1.85e-05	113	75	5	M5451
Coexpression	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	CD63 CCND1 MAPRE2 SLC1A4 PLSCR1 DENND3 TSPAN3 SLC2A3	2.30e-05	411	75	8	M19971
Coexpression	LEE_LIVER_CANCER_MYC_TGFA_UP	CD63 CCND1 SLC1A4 PLSCR1	2.85e-05	61	75	4	M3432
Coexpression	GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_UP	PREP KCNJ2 ESR1 CXCL11 SLC1A4 SLC2A3 VDR	3.99e-05	324	75	7	M41138
Coexpression	DELACROIX_RAR_TARGETS_DN	CCND1 PLSCR2 PLSCR1	5.58e-05	26	75	3	MM950
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4	GPRASP1 SLC4A8 SLC10A2 THRA TTLL3 KIAA0825 DTNA RBL2 MTMR1 CACNA1H FXYD3	2.24e-05	721	70	11	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3	GPRASP1 SLC4A8 SLC10A2 THRA TTLL3 KIAA0825 DTNA RBL2 MED12L MTMR1 CACNA1H	2.51e-05	730	70	11	Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	SLC10A2 THRA DTNA MTMR1 ZER1 CACNA1H CCND1	1.26e-04	339	70	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-1	TBC1D8 SLC4A8 CD63 TSPAN3	1.29e-04	78	70	4	GSM854287_100
CoexpressionAtlas	Myeloid Cells, DC.IIhilang-103-11b+.SLN, MHCIIhi CD11c+ Langerin- CD103- CD11b+, Lymph Node, avg-3	TBC1D8 SLC4A8 CD63 TSPAN3	1.29e-04	78	70	4	GSM538274_100
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2	SLC4A8 SLC10A2 THRA TTLL3 KIAA0825 DTNA RBL2 MED12L MTMR1 CACNA1H	1.61e-04	747	70	10	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2	TBC1D8 SLC4A8 CD63 TSPAN3	1.64e-04	83	70	4	GSM854285_100
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-3	TBC1D8 SLC4A8 CD63 TSPAN3	1.96e-04	87	70	4	GSM605836_100
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MED12L ACKR4 MAPK13 FXYD3 CLDN1 VDR	7.54e-07	182	77	6	9174fb0b7ed8f721a5c513e41fd80476a9f34332
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO6 CCND1 PLSCR2 MAPK13 FXYD3 VDR	1.09e-06	194	77	6	0ef63abcfd057079a9a6f8b27404ff521d44845d
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO6 CCND1 FXYD3 PLS1 TSPAN3 CLDN1	1.31e-06	200	77	6	f386a86b127433cbac306950443355bd723080ff
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO6 CCND1 FXYD3 PLS1 TSPAN3 CLDN1	1.31e-06	200	77	6	b75154417c215b8853186bff46d624ebd387ac4f
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TPST2 RBL2 CTIF PLS1 TNPO3	1.09e-05	168	77	5	94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7
ToppCell	droplet-Thymus-nan-21m-Myeloid-B_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MS4A1 SPATA21 ACKR4 CXCL11 PLSCR1	1.18e-05	171	77	5	8bed33f61f7d12a1ac4fba33f730d839f5ee7bef
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DTNA MED12L CCND1 CLDN1 VDR	1.29e-05	174	77	5	46bd0ef7d0541386de7a901d85d53d0176dc92bf
ToppCell	facs-Lung-EPCAM-24m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 TES SLC4A8 CD63 VDR	1.48e-05	179	77	5	51872338e54c5f3e42ca9f1c4cf1e8b0cb84afcc
ToppCell	facs-Lung-EPCAM-24m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 TES SLC4A8 CD63 VDR	1.48e-05	179	77	5	1b979e0203a2ddfe98bf6c2c80c4af1ba437a80f
ToppCell	facs\|World / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TES MAPK13 PLS1 PLSCR1 TSPAN3	1.60e-05	182	77	5	08f775135b451be709f5fc8e1cbcf63425794a2e
ToppCell	facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TBC1D8 TES SLC4A8 CD63 VDR	1.73e-05	185	77	5	19fa853f6f746ccf232a343b3c9c7a5e55800409
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACKR4 MAPK13 FXYD3 CLDN1 VDR	1.92e-05	189	77	5	6f0fc5271a7d3682f145e734abc3be6473dda2e2
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARFGEF3 CACNA1H FXYD3 CXCL11 SLC1A4	1.92e-05	189	77	5	5a0fd34928117f162c83ca1b068aa8f7069a6765
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACKR4 MAPK13 FXYD3 CLDN1 VDR	1.92e-05	189	77	5	3b9ce8964b16cb2200d30cbb0bfc711dcad2380e
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACKR4 MAPK13 FXYD3 CLDN1 VDR	1.92e-05	189	77	5	38acb307907fde68b992057714448c1561d69ee3
ToppCell	droplet-Skin-nan-21m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC4A8 SLC12A4 CCND1 ACKR4 FXYD3	1.97e-05	190	77	5	c1bfc1960a3df49c0f459454a7363804c32418ee
ToppCell	PCW_13-14-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ARFGEF3 KCNJ3 MAPK13 FXYD3 VWDE	2.02e-05	191	77	5	19832ddd559a353e1618fe853d79e3edfec6dcda
ToppCell	(1)_Osterolineage_cells-(10)_OLC-1\|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	RESF1 ADAMTS9 CD63 ACKR4 VDR	2.02e-05	191	77	5	78ad7c555409ce1391bce406bc0f3ef575329ece
ToppCell	PCW_13-14-Epithelial-Epithelial_neuroendo\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ARFGEF3 KCNJ3 CACNA1H FXYD3 VWDE	2.12e-05	193	77	5	8603d1a38955ad2529d04e4704467c73ea5bfbda
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	PLSCR4 TPST2 ADAMTS9 AK5 PLSCR1	2.12e-05	193	77	5	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	10x3'2.3-week_12-13-Hematopoietic-MK-MK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TPST2 SLC39A3 MED12L MAPRE2 SLC2A3	2.12e-05	193	77	5	3d4411b3c1cb160dec5db29f0c126d8827dfe185
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RESF1 MYO6 CCND1 PLSCR2 CLDN1	2.17e-05	194	77	5	550e61a40be2baa59520aaf5912bb99ad094ba15
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KCNJ2 KCNJ3 DENND3 SLC2A3 CLEC2B	2.17e-05	194	77	5	607b5d194ba56efa9b106f10f89368fc103712a0
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KCNJ2 KCNJ3 DENND3 SLC2A3 CLEC2B	2.17e-05	194	77	5	f5367072b259ae170cf0df3d4d871ab41be29d29
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids\|BALF-PFMC / Compartment, severity and other cell annotations on 10x 3' data (130k)	CCND1 FXYD3 CXCL11 PLS1 CLDN1	2.34e-05	197	77	5	495bfdb40b640591fbbaaa99f419bb6468cef405
ToppCell	droplet-Mammary_Gland-nan-18m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO6 CCND1 PLSCR2 MAPK13 FXYD3	2.34e-05	197	77	5	ed3a37f532741764060d297a560eeeeec279d9c4
ToppCell	Transverse-Dendritic_cell-Lymphoid_DC\|Dendritic_cell / Region, Cell class and subclass	TBC1D8 SLC12A4 MS4A1 MYO6 MAPK13	2.34e-05	197	77	5	8545baf923ddf84c5ce9414a36d810603be52401
ToppCell	T/NK_cells-NKT_cell\|T/NK_cells / Lineage and Cell class	TPST2 MYO6 CD63 DENND3 CLEC2B	2.34e-05	197	77	5	10702e61b510bfc7f54047ab3d8c700451a662b2
ToppCell	BAL-Severe-cDC_1\|Severe / Compartment, Disease Groups and Clusters	CD63 CXCL11 PLSCR1 SLC2A3 CLEC2B	2.46e-05	199	77	5	9f5750212b887f92761ade33fc6e108cd5275297
ToppCell	critical-Epithelial\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ARFGEF3 MYO6 FXYD3 PLS1 TSPAN3	2.46e-05	199	77	5	bbb44e2a52f102a6d891ead6c06d6c07221abd33
ToppCell	15-Trachea-Epithelial\|Trachea / Age, Tissue, Lineage and Cell class	ARFGEF3 MYO6 CD63 FXYD3 TSPAN3	2.46e-05	199	77	5	e0099aa95cf3ec08d7688cc97f4b917fce65a7a3
ToppCell	PSB-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ARFGEF3 MYO6 FXYD3 PLS1 TSPAN3	2.46e-05	199	77	5	58dcb0eedafa8629585dc99e53147e2287f49689
ToppCell	NS-critical-d_07-13-Epithelial\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ARFGEF3 MYO6 FXYD3 PLS1 TSPAN3	2.46e-05	199	77	5	b88a81cd2a89f4d27100c96ae4324dcee68daf83
ToppCell	tumor_Lung-Epithelial_cells\|tumor_Lung / Location, Cell class and cell subclass	ARFGEF3 MYO6 CCND1 FXYD3 TSPAN3	2.46e-05	199	77	5	56b3f6c8b561d60780d91daf6b44a9dcf616e599
ToppCell	NS-moderate-d_16-33-Epithelial\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ARFGEF3 MYO6 FXYD3 PLS1 TSPAN3	2.46e-05	199	77	5	aa2b51940115c22768c0d7493b4b60d41df3f376
ToppCell	NS-control-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ARFGEF3 MYO6 FXYD3 TSPAN3 CLDN1	2.52e-05	200	77	5	d014959891893b6d3854a471fba1dc50c6625a0a
ToppCell	Severe-Epithelial-Epithelial-\|Severe / Condition, Lineage, Cell class and cell subclass	ARFGEF3 MYO6 FXYD3 PLS1 CLDN1	2.52e-05	200	77	5	8669ce08f93eefb8ac970e30cdc4b1f908023c54
ToppCell	Severe-Epithelial\|Severe / Condition, Lineage, Cell class and cell subclass	ARFGEF3 MYO6 FXYD3 PLS1 CLDN1	2.52e-05	200	77	5	6ead9db88568bb829d564a6d8e85f71fd765bac0
ToppCell	Severe-Epithelial-Epithelial\|Severe / Condition, Lineage, Cell class and cell subclass	ARFGEF3 MYO6 FXYD3 PLS1 CLDN1	2.52e-05	200	77	5	3bd1ce2793651c9badd69f011d2531183594e5f4
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Sla\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ADCY10 KCNJ2 ESR1 KCTD4	8.11e-05	132	77	4	ddebc0b233fdbb73ceb70187945bbed8fd273f2a
ToppCell	E18.5-samps-Epithelial-Epithelial-non_alveolar-Club_cell\|E18.5-samps / Age Group, Lineage, Cell class and subclass	SPATA21 MED12L ASB14 MAPK13	1.30e-04	149	77	4	82edfecb7981d8c336cf9da7aa7e2b3f7a017a3f
ToppCell	E18.5-samps-Epithelial-Epithelial-non_alveolar\|E18.5-samps / Age Group, Lineage, Cell class and subclass	SPATA21 MED12L ASB14 MAPK13	1.30e-04	149	77	4	14a01ae540db8a350ea26a350b2e6ce6c07639d9
ToppCell	3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MXRA5 CCND1 FXYD3 CLDN1	1.33e-04	150	77	4	aa11579a57d671a55e64183d35c1340fda6dec14
ToppCell	facs-Heart-LV-18m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNJ2 MAPK13 PLS1 SLC2A3	1.36e-04	151	77	4	5893a51585a65f1902cf85124a5ed9f02b4eb82a
ToppCell	facs-Heart-LV-18m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNJ2 MAPK13 PLS1 SLC2A3	1.36e-04	151	77	4	771224e0d6fccfa4225b3adccd7bc22a89a40793
ToppCell	3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MED12L CCND1 FXYD3 CLDN1	1.43e-04	153	77	4	82b77c8bae49dd63b8f10eb67df66ca71d0bb315
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	MXRA5 MYO6 DTNA CCND1	1.58e-04	157	77	4	84f629b7f589ca8a1abc220fa740c4a6fdc1b579
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|368C / Donor, Lineage, Cell class and subclass (all cells)	TPST2 RBL2 PLS1 TNPO3	1.62e-04	158	77	4	390b9c455ed15a6804613eecfd2776949dfba146
ToppCell	droplet-Spleen-nan-24m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 CD63 CCND1 MAPK13	1.62e-04	158	77	4	e1a8dba5a88bc3ce112829c5ecb112cbbee5b078
ToppCell	droplet-Spleen-nan-24m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 CD63 CCND1 MAPK13	1.62e-04	158	77	4	72e4f8ae137a7dddee0dc6236532e0711065e6af
ToppCell	droplet-Thymus-nan-21m-Myeloid-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 CCND1 MAPK13 CLDN1	1.74e-04	161	77	4	441ebd3c029861d833fbcf8a68fc740d9de8ef2f
ToppCell	droplet-Lung-30m-Hematologic-myeloid-neutrophil\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD63 MAPK13 PLS1 SLC2A3	1.79e-04	162	77	4	9c9a63adb692651ea5a52cc77b02c5ce11d0ccea
ToppCell	droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD63 MAPK13 PLS1 SLC2A3	1.79e-04	162	77	4	1d29983b22f963b34e72cfd1eec328d2d7c4932f
ToppCell	droplet-Lung-21m-Hematologic-myeloid-neutrophil\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KCNJ2 MED12L MAPK13 SLC2A3	1.79e-04	162	77	4	f24eb596653180040bfdefad9c246fc42cbfaac8
ToppCell	droplet-Lung-21m-Hematologic-myeloid-neutrophil-neutrophil\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KCNJ2 MED12L MAPK13 SLC2A3	1.79e-04	162	77	4	1a953e165b7e469815294728350ec13d27c9bd9d
ToppCell	droplet-Spleen-nan-18m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD63 MAPK13 SLC2A3 CLDN1	1.83e-04	163	77	4	bc37c5d9f48b16096d5313657563f3ec84028c8c
ToppCell	droplet-Spleen-nan-21m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 CD63 CCND1 MAPK13	1.92e-04	165	77	4	fbd84f211ad645c91b9f45a0815391606f3206ac
ToppCell	droplet-Spleen-nan-21m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 CD63 CCND1 MAPK13	1.92e-04	165	77	4	6fbdfacb49e627712ac999d40ae22dcb390edd3e
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TPST2 MYO6 RBL2 CLEC2B	2.05e-04	168	77	4	b94b1f37c92e019d01ecfa3b7cc6797b6e4a56ff
ToppCell	Immune_cells-Neutrophils\|Immune_cells / Lineage and Cell class	CD63 MAPK13 PLSCR1 SLC2A3	2.05e-04	168	77	4	3539f802fe0143da1462df0618f78f9f15143f71
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNJ2 CD63 CCND1 MAPRE2	2.10e-04	169	77	4	780fb0050852626062a729dd1b82b0cf61e7e9ca
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PREP SPATA21 AK5 CLEC2B	2.10e-04	169	77	4	96aafb687b34d4b59f75c24e176b0b442e864245
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KCNJ2 CD63 CACNA1H CLDN1	2.15e-04	170	77	4	14aa86a4f526ed6986afcb28c49225522055550c
ToppCell	facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TBC1D8 TES CXCL11 PTH	2.15e-04	170	77	4	df1a34a69ae404c56f00751a01f52359535f5469
ToppCell	ileum\|World / shred on tissue and cell subclass	SLC10A2 RESF1 BTNL3 PLS1	2.15e-04	170	77	4	9f1211bd4287620e19a59f21e6ecdca3e42e0260
ToppCell	droplet-Thymus-nan-3m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 CD63 CCND1 CLDN1	2.20e-04	171	77	4	25493a4a7b636920e2cfd984542cc500709c9dcf
ToppCell	droplet-Thymus-nan-3m-Myeloid-professional_antigen_presenting_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 CD63 CCND1 CLDN1	2.20e-04	171	77	4	508b41e3ad2638f9dd546d251b13ff60fc8c3207
ToppCell	ILEUM-non-inflamed-(3)_Inf._Macrophages\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	KCNJ2 CXCL11 PLSCR1 CLDN1	2.30e-04	173	77	4	a8db746992a915a8431ac5c155612e89c4af3cad
ToppCell	droplet-Thymus-nan-3m-Myeloid-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 CD63 CCND1 CLDN1	2.30e-04	173	77	4	63f03abca84ae021ff34ff34537838aa8a1ccd11
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EFCAB5 SLC4A8 CCND1 ASB14	2.30e-04	173	77	4	b6aed736d8480e3a6a5718aabd2fb79b1b75fa48
ToppCell	TCGA-Brain-Primary_Tumor\|TCGA-Brain / Sample_Type by Project: Shred V9	THRA SLC12A4 DTNA TSPAN3	2.30e-04	173	77	4	f6ba22661e67c17d49d1058d4170ba8f36bf47f0
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 SLC4A8 CCND1 TSPAN3	2.35e-04	174	77	4	7be0c6248e77f2d0260b852b01e17892f7828f1b
ToppCell	droplet-Marrow-nan-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD63 MAPK13 PLSCR1 SLC2A3	2.35e-04	174	77	4	4b749ac9f05776c0c56b74daca833bd0b5704299
ToppCell	droplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 MED12L CCND1 CLDN1	2.35e-04	174	77	4	2afa5eea54b67c549c5058ece98296eee3829c11
ToppCell	3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PREP MAPK13 FXYD3 PLS1	2.40e-04	175	77	4	8727252bcbc70bfa2ff72e7421df9cfe6fd4eed7
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TBC1D8 SLC4A8 CCND1 TSPAN3	2.40e-04	175	77	4	1b910c08d2bfbcc77431ee66103e63a11a9d39fe
ToppCell	droplet-Liver-Npc-21m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TES MS4A1 ASB14 FXYD3	2.40e-04	175	77	4	046e841811b22c39f80a9752f3223c1906de6f20
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DTNA ZFYVE26 PLS1 SLC2A3	2.40e-04	175	77	4	bb898796662b97f7459b7dda7cecf6a9bde8b055
ToppCell	3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PREP MAPK13 FXYD3 PLS1	2.40e-04	175	77	4	c083abe368e5c0dc2b0f27f375c9271a2d7ff64f
ToppCell	facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 MED12L CCND1 PTH	2.45e-04	176	77	4	74f851a398c7562dd713bc0d8d488c0037243112
ToppCell	facs-Marrow-T_cells-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 MED12L CCND1 PTH	2.45e-04	176	77	4	31b5459a978d5cdde0af03a77401e0464d8c95ba
ToppCell	facs-Lung-EPCAM-3m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 TES CXCL11 PTH	2.50e-04	177	77	4	d445167dae956e641386f84ab3ae9f47c089e09a
ToppCell	droplet-Limb_Muscle-nan-21m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTLL3 KIAA0825 FXYD3 CLDN1	2.50e-04	177	77	4	291231b1520c135e92739e201495fe1935efa927
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D8 TES CXCL11 PTH	2.56e-04	178	77	4	0b456ac768e026c3ecd5a9a4f43d6f126e7685a1
ToppCell	droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARFGEF3 MS4A1 DTNA ASB14	2.61e-04	179	77	4	4135f9e8cd8494cbc189e5210dded84659643fb8
ToppCell	droplet-Limb_Muscle-Pre-Sort\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS9 CD63 CACNA1H FXYD3	2.67e-04	180	77	4	af2bafcd1b2082629de3ea336711add01565c4c4
ToppCell	Control-Epithelial-Goblet\|Control / Disease state, Lineage and Cell class	ARFGEF3 CCND1 FXYD3 CLDN1	2.67e-04	180	77	4	5293d23b8b8ea587239ffde561b70bad01632521
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KCNJ2 KCNJ3 DENND3 SLC2A3	2.67e-04	180	77	4	cf7d8bf9eee2dfab2c8a6780e296b05ad42041bf
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS9 CD63 CACNA1H FXYD3	2.67e-04	180	77	4	f29a995cf6e1a1836ed68b73258d9370bf3d4434
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACKR4 MAPK13 FXYD3 VDR	2.73e-04	181	77	4	a5e770b5b5d57cbac18560828e89f7c96b687743
ToppCell	facs-Marrow-T-cells-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARFGEF3 CACNA1H HUWE1 PLS1	2.73e-04	181	77	4	57f0cc749ae8b6a3d77e2af31f9a6e4739c57049
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACKR4 MAPK13 FXYD3 VDR	2.73e-04	181	77	4	504b1af1951a7a20ef5db69d84c20630ec64095b
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACKR4 MAPK13 FXYD3 VDR	2.73e-04	181	77	4	a55ec36d2393f7a376feb42b22aee75dfdf4c383
ToppCell	facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARFGEF3 CACNA1H HUWE1 PLS1	2.73e-04	181	77	4	d01b35cc2fc57991a35be6a06cb7351fbabd9a11
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DTNA MED12L CLDN1 VDR	2.84e-04	183	77	4	83592c332b1e82673f993d37c7f480befdc3dcda
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MED12L CCND1 CXCL11 CLDN1	2.84e-04	183	77	4	bd78e5c2670e67b4363078e3ca5a5b7081d24b7e
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MED12L CCND1 CXCL11 CLDN1	2.84e-04	183	77	4	d1bf3abf42eb9d7facf775becf1338d1faadd647
ToppCell	facs-Brain_Non-Myeloid-Striatum_\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACKR4 FXYD3 CLDN1 VDR	2.84e-04	183	77	4	824ecda1219fb596a01bf5cfeee29a6daa462098
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACKR4 FXYD3 CLDN1 VDR	2.84e-04	183	77	4	82b84ee065fb573688d59da97a327152a1ba294c
ToppCell	(7)_Epithelial-H_(AT1)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CCDC60 CCND1 FXYD3 CLDN1	2.90e-04	184	77	4	1f76b37c265b519171b767a52d48f31f0cdc4a3c
Computational	Ovary genes.	MXRA5 TES CCND1 MAPRE2 PLSCR1 TSPAN3 SLC2A3 CLEC2B	1.46e-04	368	46	8	MODULE_1
Drug	Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A	TPST2 TES SLC4A8 RESF1 DTNA KCNJ3 ESR1 MAPRE2	2.03e-07	197	72	8	2812_DN
Drug	sodium	SLC4A8 SLC10A2 SLC12A4 KCNJ2 KCNJ3 ESR1 SCN10A PKLR CACNA1H HUWE1 FXYD3 PTH SLC1A4 SLC2A3 CLEC2B	2.08e-07	944	72	15	CID000000923
Drug	Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A	DTNA ESR1 MTMR1 ZER1 MAPK13 VPS13B CLDN1	2.12e-06	187	72	7	5012_UP
Drug	Pimozide [2062-78-4]; Up 200; 8.6uM; PC3; HT_HG-U133A	SLC4A8 DTNA ESR1 FXYD3 SLC1A4 DENND3 CLEC2B	2.70e-06	194	72	7	7132_UP
Drug	Lansoprazole [103577-45-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A	MS4A1 PKLR ZER1 CACNA1H CTIF SLC1A4 CLEC2B	2.79e-06	195	72	7	3529_UP
Drug	Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; MCF7; HT_HG-U133A	DTNA RBL2 KCNJ3 ESR1 CACNA1H MAPRE2 VPS13B	3.09e-06	198	72	7	7322_UP
Drug	tetraethylenepentamine pentahydrochloride; Up 200; 100uM; MCF7; HG-U133A	TPST2 KLHL9 RBL2 ANKRD26 HUWE1 DENND3 TSPAN3	3.19e-06	199	72	7	406_UP
Drug	D-tryptophan methyl ester	THRA PLS1 VDR	4.91e-06	11	72	3	CID000077980
Drug	4-epidoxorubicin	MSH6 THRA MS4A1 RBL2 ESR1 PSMB3 PKLR CCND1 HUWE1 MAPK13 PTH CLDN1	6.20e-06	788	72	12	CID000001690
Drug	vitamin D3 analog	ESR1 CCND1 PTH VDR	8.52e-06	41	72	4	CID006438384
Drug	EB1213	PTH VDR	9.86e-06	2	72	2	CID006439508
Drug	AC1L4NFJ	TES ESR1	9.86e-06	2	72	2	CID000160328
Drug	AC1L3BVK	PTH VDR	9.86e-06	2	72	2	CID000086590
Drug	3-(4-(1,2-diphenylbut-1-enyl)phenyl)acrylic acid	ESR1 CCND1	9.86e-06	2	72	2	ctd:C087550
Drug	bis(4-oxyphenyl)sulfide	THRA ESR1	9.86e-06	2	72	2	ctd:C069693
Drug	K-Cl	TES SLC12A4 MYO6 KCNJ2 KCNJ3 ESR1 MAPK13 PTH CLEC2B VDR	1.14e-05	567	72	10	CID000004873
Drug	thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	TBC1D8 DTNA ESR1 ZER1 SLC1A4 TNPO3	1.76e-05	172	72	6	6989_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	KCNJ2 ZER1 MAPRE2 SLC1A4 DENND3 CLDN1	1.88e-05	174	72	6	7136_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	PLSCR4 TPST2 KCNJ2 MAPRE2 DENND3 CLDN1	2.07e-05	177	72	6	3993_UP
Drug	2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol	PTH VDR	2.95e-05	3	72	2	ctd:C521167
Drug	torachrysone	PREP ESR1	2.95e-05	3	72	2	CID005321977
Drug	1,25-dihydroxy-16-ene-vitamin D3	PTH VDR	2.95e-05	3	72	2	ctd:C087630
Drug	1 alpha-hydroxyergocalciferol	PTH VDR	2.95e-05	3	72	2	ctd:C042533
Drug	P-312	RBL2 CCND1	2.95e-05	3	72	2	CID000199977
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	DTNA ESR1 ANKRD26 ZER1 MAPK13 VDR	3.00e-05	189	72	6	1646_UP
Drug	Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A	KLHL9 THRA KCNJ3 ESR1 SCN10A MTMR1	3.09e-05	190	72	6	4115_DN
Drug	radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	MSH6 RBL2 ESR1 ANKRD26 ZER1 VDR	3.09e-05	190	72	6	836_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A	DTNA ESR1 CTIF MAPRE2 SLC1A4 DENND3	3.18e-05	191	72	6	3803_DN
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A	GPRASP1 MS4A1 ESR1 SCN10A ANKRD26 VPS13B	3.27e-05	192	72	6	4144_DN
Drug	STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A	DTNA KCNJ3 ESR1 ANKRD26 MTMR1 ZER1	3.37e-05	193	72	6	6869_DN
Drug	Hecogenin [467-55-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	THRA ESR1 SCN10A ZER1 MAPK13 CLDN1	3.57e-05	195	72	6	7175_UP
Drug	cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A	TPST2 DTNA RBL2 ESR1 CACNA1H DENND3	3.57e-05	195	72	6	207_UP
Drug	ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA	THRA DTNA ESR1 CACNA1H CTIF CLDN1	3.67e-05	196	72	6	918_UP
Drug	6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A	KCNJ3 ESR1 SCN10A CACNA1H CTIF VDR	3.67e-05	196	72	6	4833_UP
Drug	Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; PC3; HT_HG-U133A	DTNA ESR1 PKLR ZER1 SLC1A4 SLC2A3	3.67e-05	196	72	6	5112_UP
Drug	Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A	GPRASP1 TES ESR1 MTMR1 ZER1 ZFYVE26	3.67e-05	196	72	6	1708_UP
Drug	alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A	BTNL3 AK5 ESR1 ZER1 HUWE1 VPS13B	3.67e-05	196	72	6	6169_UP
Drug	Estriol [50-27-1]; Up 200; 13.8uM; PC3; HT_HG-U133A	THRA KCNJ3 SCN10A ANKRD26 CTIF HUWE1	3.78e-05	197	72	6	5866_UP
Drug	Mometasone furoate [83919-23-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A	DTNA ESR1 SCN10A MAPK13 MAPRE2 SLC1A4	3.78e-05	197	72	6	5541_UP
Drug	Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; PC3; HT_HG-U133A	THRA DTNA KCNJ2 ESR1 ZER1 MAPRE2	3.78e-05	197	72	6	6360_UP
Drug	Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; PC3; HT_HG-U133A	THRA DTNA AK5 ZER1 CLDN1 VDR	3.78e-05	197	72	6	4233_DN
Drug	Moxonidine [75438-57-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A	DTNA SCN10A ZER1 CACNA1H SLC1A4 VPS13B	3.78e-05	197	72	6	7343_UP
Drug	sodium 4-phenylbutyrate; Up 200; 1000uM; MCF7; HG-U133A	TPST2 KLHL9 RBL2 ANKRD26 ZFYVE26 TSPAN3	3.78e-05	197	72	6	407_UP
Drug	Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; HL60; HT_HG-U133A	ADCY10 MYO6 ANKRD26 CCND1 MAPK13 VDR	3.78e-05	197	72	6	2356_UP
Drug	Aztreonam [78110-38-0]; Up 200; 9.2uM; PC3; HT_HG-U133A	SLC10A2 RBL2 ESR1 MTMR1 ZER1 SLC1A4	3.89e-05	198	72	6	2118_UP
Drug	Chlorambucil [305-03-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A	PLSCR4 BTNL3 DTNA CACNA1H CTIF PLSCR2	3.89e-05	198	72	6	4345_UP
Drug	Pizotifen malate [5189-11-7]; Up 200; 9.4uM; HL60; HT_HG-U133A	THRA BTNL3 ADAMTS9 ESR1 ZER1 MAPK13	3.89e-05	198	72	6	3134_UP
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	THRA DTNA ZER1 CACNA1H CTIF VDR	3.89e-05	198	72	6	3882_DN
Drug	Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; MCF7; HT_HG-U133A	SLC12A4 DTNA ZER1 CACNA1H CTIF DENND3	3.89e-05	198	72	6	3509_UP
Drug	Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A	ADCY10 GPRASP1 MS4A1 ESR1 PLSCR2 HUWE1	3.89e-05	198	72	6	5524_UP
Drug	17-AAG; Down 200; 0.1uM; MCF7; HG-U133A	MS4A1 RBL2 KCNJ2 KCNJ3 ESR1 VDR	3.89e-05	198	72	6	221_DN
Drug	Paroxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A	MS4A1 DTNA ZER1 CACNA1H CTIF SLC2A3	3.89e-05	198	72	6	4378_UP
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; PC3; HT_HG-U133A	DTNA KCNJ2 AK5 ESR1 ANKRD26 ZER1	4.00e-05	199	72	6	6349_UP
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A	SLC10A2 DTNA AK5 ANKRD26 SLC1A4 CLDN1	4.00e-05	199	72	6	3741_DN
Drug	rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A	THRA DTNA ESR1 SCN10A CACNA1H HUWE1	4.00e-05	199	72	6	5927_UP
Drug	Gly-His-Lys acetate salt; Up 200; 1uM; MCF7; HT_HG-U133A	TBC1D8 KCNJ3 ZFYVE26 TNPO3 PLSCR1 TSPAN3	4.00e-05	199	72	6	6575_UP
Drug	SC-58125; Down 200; 10uM; MCF7; HG-U133A	DTNA RBL2 ZBTB10 DENND3 CLEC2B VDR	4.00e-05	199	72	6	254_DN
Drug	tetraethylenepentamine pentahydrochloride; Up 200; 10uM; MCF7; HG-U133A	TPST2 KLHL9 RBL2 HUWE1 DENND3 TSPAN3	4.00e-05	199	72	6	405_UP
Drug	Merbromin [129-16-8]; Down 200; 5uM; HL60; HT_HG-U133A	BTNL3 SCN10A ZER1 CTIF MAPK13 VDR	4.00e-05	199	72	6	2577_DN
Drug	azathioprine, USP; Down 200; 100uM; MCF7; HG-U133A	TPST2 SLC12A4 MYO6 CYP3A43 VPS13B VDR	4.11e-05	200	72	6	338_DN
Drug	Meglumine [6284-40-8]; Up 200; 20.4uM; HL60; HT_HG-U133A	MYO6 KCNJ2 AK5 ESR1 FXYD3 VPS13B	4.11e-05	200	72	6	3068_UP
Drug	mobs	TES PTH VDR	4.47e-05	22	72	3	CID003674064
Drug	temsirolimus	THRA ESR1 CCND1	5.85e-05	24	72	3	ctd:C401859
Drug	N-(2-hydroxypropyl)methacrylamide	PKLR CD63 CCND1	5.85e-05	24	72	3	CID000038622
Drug	AC1NS4C8	PTH VDR	5.89e-05	4	72	2	CID000003070
Drug	2-(4-hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-yl-ethoxy)-benzyl)-1H-indol-5-ol	ESR1 CCND1	5.89e-05	4	72	2	ctd:C439584
Drug	AC1L1VK9	ESR1 CCND1	5.89e-05	4	72	2	CID000036323
Drug	1,25(OH)2-16-ene-23-yne-26,27-hexafluoro-19-nor-D3	PTH VDR	5.89e-05	4	72	2	ctd:C408047
Drug	2,2',4,4',5-brominated diphenyl ether	THRA ESR1 CCND1	7.48e-05	26	72	3	ctd:C477694
Drug	alfacalcidol	SLC10A2 PTH VDR	7.48e-05	26	72	3	ctd:C008088
Drug	Barium	SLC12A4 KCNJ2 KCNJ3 CACNA1H	8.04e-05	72	72	4	ctd:D001464
Drug	paraben	ESR1 SCN10A PLS1	9.39e-05	28	72	3	CID000007175
Drug	PD98059	RBL2 ESR1 CCND1 MAPK13 PTH VDR	9.58e-05	233	72	6	CID000004713
Drug	cholylsarcosine	SLC10A2 VDR	9.80e-05	5	72	2	CID000125082
Drug	AC1O5R3Z	PTH VDR	9.80e-05	5	72	2	CID006439163
Drug	[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[4-(3-oxobutyl)phenoxy]oxan-3-yl] 3,4,5-trihydroxybenzoate	PREP ESR1	9.80e-05	5	72	2	CID010390322
Drug	DB08594	SLC10A2 CCND1	9.80e-05	5	72	2	CID005289428
Drug	AC1NR2XO	PTH VDR	9.80e-05	5	72	2	CID005283746
Drug	AC1MHEDL	FXYD3 CXCL11 PTH VDR	1.10e-04	78	72	4	CID003002890
Drug	Phosphorus	DTNA MAPK13 PTH VDR	1.21e-04	80	72	4	ctd:D010758
Drug	Butyrophenones	ESR1 CCND1	1.47e-04	6	72	2	ctd:D002090
Drug	4-((4-hydroxyphenylimino)methylbenzene-1,2-diol	ESR1 CCND1	1.47e-04	6	72	2	ctd:C000593866
Drug	tegaserod	THRA ESR1	1.47e-04	6	72	2	ctd:C105050
Drug	alendronate	NEK8 ESR1 PTH VDR	1.91e-04	90	72	4	CID000002088
Drug	Vanadates	PLSCR4 ARFGEF3 TES SLC12A4 ESR1 PSMB3 KCTD4 MED12L ZBTB10 MTMR1 PLSCR1 SLC2A3 VDR	1.99e-04	1302	72	13	ctd:D014638
Drug	AC1L9MD8	ESR1 CCND1	2.05e-04	7	72	2	CID000448803
Drug	DIBA-1	RBL2 ESR1	2.05e-04	7	72	2	ctd:C100805
Drug	4-fluorobenzoyl-TN-14003	ESR1 CCND1	2.05e-04	7	72	2	ctd:C477728
Drug	bptc	PTH VDR	2.05e-04	7	72	2	CID000167153
Drug	maxacalcitol	PTH VDR	2.05e-04	7	72	2	ctd:C051883
Drug	lacidipine	ESR1 VDR	2.05e-04	7	72	2	ctd:C060285
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	KCNJ3 ESR1 MTMR1 CCND1 FXYD3	2.10e-04	171	72	5	1000_DN
Drug	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide	KCNJ2 ESR1 CCND1 PTH SLC2A3	2.22e-04	173	72	5	ctd:C063509
Drug	beta Carotene	PLSCR4 CYP3A43 ESR1 CCND1 PLSCR1	2.34e-04	175	72	5	ctd:D019207
Drug	Zidovudine	SLC12A4 RBL2 ESR1 CCND1 SLC1A4 PLSCR1 SLC2A3 VDR	2.36e-04	521	72	8	ctd:D015215
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	PLSCR4 KCNJ2 MAPRE2 DENND3 CLDN1	2.40e-04	176	72	5	4565_UP
Drug	Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A	TES DTNA ESR1 ZER1 SLC1A4	2.40e-04	176	72	5	5291_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	DTNA KCNJ3 ESR1 MTMR1 CCND1	2.40e-04	176	72	5	1535_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	KCNJ3 ESR1 MTMR1 CCND1 MAPK13	2.40e-04	176	72	5	3312_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	PLSCR4 TPST2 KCNJ2 ZER1 DENND3	2.46e-04	177	72	5	5745_UP
Disease	Rickets	PTH VDR	3.51e-05	4	72	2	C0035579
Disease	secondary hyperparathyroidism (biomarker_via_orthology)	PTH VDR	3.51e-05	4	72	2	DOID:12466 (biomarker_via_orthology)
Disease	male breast carcinoma	ESR1 CCND1	1.63e-04	8	72	2	EFO_0006861
Disease	Shortened QT interval	KCNJ2 SCN10A	3.18e-04	11	72	2	C0151879
Disease	leukemia	MSH6 ESR1 CCND1	3.34e-04	55	72	3	C0023418
Disease	Chronic Lymphocytic Leukemia	RBL2 CCND1 VDR	3.34e-04	55	72	3	C0023434
Disease	Endometrial Neoplasms	MSH6 ESR1 CCND1	3.90e-04	58	72	3	C0014170
Disease	Malignant neoplasm of liver	SPATA21 ESR1 CCND1 PLS1	4.10e-04	142	72	4	C0345904
Disease	Liver neoplasms	SPATA21 ESR1 CCND1 PLS1	4.10e-04	142	72	4	C0023903
Disease	taurolithocholate 3-sulfate measurement	SLC10A2 ESR1	4.50e-04	13	72	2	EFO_0021036
Disease	T wave morphology measurement	PREP SCN10A	5.24e-04	14	72	2	EFO_0008398
Disease	Endometrial Carcinoma	MSH6 ESR1 CCND1	7.36e-04	72	72	3	C0476089
Disease	Uremia	PTH VDR	7.80e-04	17	72	2	C0041948
Disease	squamous cell carcinoma (is_implicated_in)	CCND1 VDR	8.76e-04	18	72	2	DOID:1749 (is_implicated_in)
Disease	osteoporosis (implicated_via_orthology)	PTH VDR	9.77e-04	19	72	2	DOID:11476 (implicated_via_orthology)
Disease	Pseudopelade	CLDN1 VDR	9.77e-04	19	72	2	C0086873
Disease	Brugada syndrome	SCN10A MAPRE2	9.77e-04	19	72	2	MONDO_0015263
Disease	Malignant neoplasm of breast	MSH6 SPATA21 ESR1 ZFYVE26 CCND1 CTIF VPS13B CLDN1 VDR	1.18e-03	1074	72	9	C0006142
Disease	vitiligo (is_implicated_in)	ESR1 VDR	1.20e-03	21	72	2	DOID:12306 (is_implicated_in)
Disease	osteoporosis (biomarker_via_orthology)	ESR1 PTH	1.31e-03	22	72	2	DOID:11476 (biomarker_via_orthology)
Disease	atopic dermatitis (is_implicated_in)	CLDN1 VDR	1.84e-03	26	72	2	DOID:3310 (is_implicated_in)
Disease	obesity (implicated_via_orthology)	ADAMTS9 ESR1 MED12L ANKRD26	1.91e-03	215	72	4	DOID:9970 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of ovary	MSH6 ESR1	2.28e-03	29	72	2	C0496920

Protein segments in the cluster

Peptide	Gene	Start	Entry
LKRCVDIGMMKEFIL	VDR	81	P11473
GCEALVVKKLQEIMM	TSPAN3	196	O60637
ALCGVVMGMIIVFFK	BTNL3	246	Q6UXE8
AAKLCDKMALFMVEG	CTIF	431	O43310
LLGATCMFVASKMKE	CCND1	101	P24385
EIMEMLLRKGKIFCL	ASB14	231	A6NK59
CFNMGQIVLAKKMLR	ADCY10	1141	Q96PN6
KNFMLLIEQLGMECK	ANKRD26	706	Q9UPS8
CLVKGKMIMNSLSLF	MS4A1	111	P11836
FKVGTAKVNCMVMAD	DENND3	941	A2RUS2
VAKVFNKMACVLARM	GKN3P	71	P0CG01
NKMACVLARMDKAVF	GKN3P	76	P0CG01
EAGFCLQDKMEILMK	CCDC60	396	Q8IWA6
IKAIVKDVMYICPFM	MTMR1	106	Q13613
VMAMKGKNCVAIAAD	PSMB3	11	P49720
IDAFIIGAVMAKMAK	KCNJ2	171	P63252
LLMCAIYVMAKVTKE	RBL2	891	Q08999
MKALIQMLEICIGFV	ACKR4	196	Q9NPB9
MAVEGGMKCVKFLLY	CD63	1	P08962
MKKAFMRGVCALNLE	POC5	351	Q8NA72
IEVGAVFAVLKAIMM	MED12L	1171	Q86YW9
VFAVLKAIMMLGDAK	MED12L	1176	Q86YW9
EKLGLICMCLKSIMG	KIAA0825	1046	Q8IV33
MGGFMEDLRKCKIIF	AK5	366	Q9Y6K8
KGMMAGAEKLVECLL	DDX58	146	O95786
VEVKPKMVMTVFACL	PLS1	606	Q14651
KMVMTVFACLMGKGL	PLS1	611	Q14651
DVKMKAVMIGACFLI	PLSCR1	286	O15162
RDLDVKMKAVMIGAC	PLSCR2	271	Q9NRY7
KMKAVMIGACFLIDY	PLSCR2	276	Q9NRY7
DVKMKAMIFGACFLI	PLSCR4	301	Q9NRQ2
KCVEGMVEIFDMLLA	ESR1	416	P03372
PLKVFMDVCLKEKFM	PRAMEF18	146	Q5VWM3
LEMKLTKVAMLICAG	OPN5	246	Q6U736
KVQGLEGIKMAMVAC	NEK8	606	Q86SG6
ETLKFEAIMMALKCG	KCTD4	221	Q8WVF5
FTGGMKEQDLMCIKL	KLHL9	81	Q9P2J3
CIMAEMLTGKTLFKG	MAPK13	211	O15264
AEKVFLAQKMMIGRC	PKLR	346	P30613
ALEGFKVMCKIIGIM	MSH6	861	P52701
CGMMEALLKVIKFLG	HUWE1	406	Q7Z6Z7
MKISCVLGKLLMLFE	OOSP4A	1	A0A2R8YFL7
FGCVIAQVGVMDMLK	PREP	571	P48147
KMMKVVQVACYEILG	EFCAB5	1286	A4FU69
LMIRGKLLKIFCAGM	ADAMTS9	1756	Q9P2N4
KFKEMVPIISQCGDM	CYP3A43	141	Q9HB55
FVATVGMKCMKCLED	CLDN1	96	O95832
MCLMKFVKGLGEVDC	ARFGEF3	1356	Q5TH69
MDMLFPGCISLKKVK	MAPRE2	91	Q15555
AVKMALATLCGGKIM	DTNA	131	Q9Y4J8
CFMGLCKVAKSVEML	SLC2A3	106	P11169
MVIKMVALGLFGQKC	CACNA1H	151	O95180
MSVKGMAIALAVILC	CXCL11	1	O14625
MFSMGCNVEIKKFLG	SLC10A2	46	Q12908
MGIIIVMSAKCKCKF	FXYD3	51	Q14802
AMIPCFGAKEEVSMK	GPRASP1	641	Q5JY77
VEGMVFCSVECKKRM	TES	406	Q9UGI8
FRQGFMKCLLEVEKM	SPATA21	81	Q7Z572
INKDLLMAAGCIKMT	RESF1	416	Q9HCM1
VAKILCMVGVFFFML	SLC39A3	6	Q9BRY0
FVLMGCSVFMTAILK	SLC4A8	886	Q2Y0W8
MKCLMEKLFDFLGSL	HERC2P3	806	Q9BVR0
NMMEIEKVKGFCQVV	SLC12A4	751	Q9UP95
MMVPADVFVGICAKF	B3GALT9	266	A8MXE2
MMTKHKKCFIIVGVL	CLEC2B	1	Q92478
AELVFKCVKGFMMEM	C12orf4	491	Q9NQ89
NCMMVRVFGKGFKEL	VWDE	941	Q8N2E2
KAIEVMYAQCMEVGK	TPST2	216	O60704
EAVGKMGFVVTMLKL	ZER1	516	Q7Z7L7
VGIMFLVGSKIVEMK	SLC1A4	271	P43007
VAVFTGECVMKMFAL	SCN10A	1516	Q9Y5Y9
CMFRTEKIRKLVAMG	TBC1D8	491	O95759
LLVEGFTIKKPMAMC	TTLL3	531	Q9Y4R7
AGTDEKMLMKVFRCL	TNPO3	191	Q9Y5L0
CLKGIMGVKDFEENM	VPS13B	456	Q7Z7G8
RFKKCIAVGMAMDLV	THRA	111	P10827
MVCKKIFMLAASVGI	ZBTB10	781	Q96DT7
DMAKVMIVMLAICFL	PTH	6	P01270
MDVACKVMLGGKNVE	ZFYVE26	2371	Q68DK2
AFMVKNIVPKLGMCL	TFIP11	606	Q9UBB9
IVDAFLIGCMFIKMS	KCNJ3	171	P48549
VKLNCMAMGIPKADI	MXRA5	2751	Q9NR99
DFIRMCTAMKKIGLD	MYO6	316	Q9UM54